Semaglutide and longevity: A comprehensive overview
Recent studies suggest that semaglutide, a glucagon-like peptide-1 receptor agonist used to treat type 2 diabetes and obesity, may have potential longevity benefits. Research indicates that adding semaglutide to standard care could increase life-years free of cardiovascular disease events, particularly in individuals with higher baseline risk and younger age at...